The finding comes from the first study of the risk of developing anaplastic large-cell lymphoma (ACLC) after implant reconstruction following a cancer-directed mastectomy.
The incidence rate of anaplastic large-cell lymphoma (ALCL) of the breast is increasing rapidly among US women, likely reflecting an increase in the use of textured implants for breast augmentation.